Symphony Asia Holdings
Navis, Symphony buy French furniture brand Christian Liaigre
Navis Capital Partners and Symphony International Holdings have acquired Christian Liaigre Group, a French luxury furniture brand that is looking to expand in Asia, from Bridgepoint Development Capital for an undisclosed sum.
Symphony-backed Zenith Pharmaceuticals exits nine-year investee Strides Arcolab
Zenith Pharmaceuticals, the majority-owned asset of Symphony Capital, is nearing the completion of its exit from Indian pharmaceutical firm Strides Arcolab, with reports that Zenith is poised to see 5.7x returns on its nine-year investment.
Sehgal in litigation with SCPL in Singapore over bonus, Parkway exit
Sanjay Sehgal, currently Managing Partner and CEO at East West Capital, has filed a suit in Singapore's High Court against the firm where he was formerly a partner, Symphony Capital Partners Ltd., over a bonus allegedly due to him, including profits from...
SVCA Awards, Hall of Fame showcase Singapore's private equity and VC brightest
The Singapore Venture Capital and Private Equity Association (SVCA) has released the results of its inaugural SVCA Annual Awards, with winners recognized in four categories, as well as inducting five local VC and private equity pioneers into its Hall...
China stakes its claim
PRC dominates as fundraising and IPOs boom in 1H2010
Parkway Holdings playing hardball
The leading contenders to take majority control of Singaporean hospital management firm Parkway Holdings Ltd. have separately experienced hurdles in their quest to obtain their acquisition target, extending the highly contested race that began in March.
Khazanah may pick up Amanresorts
Malaysian SWF Khazanah Nasional, which has been more and more active in direct investments over the past 18 months, is now seeking to pick up a controlling stake in luxury resort chain Amanresorts from its current owner, Indian real estate developer DLF...
Asian buyers are back
TPG, CVC AP exits show regional corporate appetite
Symphony partially exits Strides Arcolab
Symphony Capital has sold shares in its long-term Indian medical investment Strides Arcolab, equivalent to just under $5 million.